7 result(s) displayed (1 - 7 of 7):

Merck, Schering-Plough and talent retention (from Corporate Dealmaker)

Merck & Co. (NYSE:MRK) hopes to close its $41.1 billion deal to acquire Schering-Plough Corp. (NYSE:SGP) by year's end. But in order for the transaction to ultimately succeed, some of the most difficult decisions around human capital should be happening now.On Monday, Merck announced that Margie McGlynn, president of global...

Posted on August 3, 2009 11:01 AM

Merck, Schering aim to settle shareholder suit (from Corporate Dealmaker)

Merck & Co. (NYSE:MRK) and Schering-Plough Corp. (NYSE:SGP) sure are spending a lot of time in court. On Friday, the drugmakers announced proposed settlements to resolve consolidated class actions over their proposed $41.1 billion merger. The companies' shareholders filed the suits on June 25, requesting more information about the tie-up....

Posted on July 24, 2009 11:11 AM

Merck, Schering iron out potential merger wrinkle (from Corporate Dealmaker)

Merck & Co. (NYSE:MRK) and Schering-Plough Corp. (NYSE:SGP) have agreed to settle civil claims related to their jointly marketed cholesterol drugs. The companies were accused of delaying the release of unfavorable test results on Vytorin and Zetia, blockbuster drugs marketed through a Merck-Schering-Plough joint venture. On Wednesday, the partners settled...

Posted on July 15, 2009 1:52 PM

Dr. Scholl's to the data room? (from Corporate Dealmaker)

The latest Corporate Dealmaker column is up on our Deal magazine site. It's a look at the prime consumer brands, including Dr. Scholl's, that may or may not remain a part of the pharma behemoths being formed in the two big deals announced in the first quarter. The deals, of...

Posted on April 1, 2009 12:30 PM

Merck-Schering, as seen from Asia (from Corporate Dealmaker)

In case you were wondering, or even if you weren't:The combination of Merck & Co. (NYSE:MRK) and Schering-Plough Corp. (NYSE:SGP) brings together two complementary operations in Asia. Merck is mainly in Japan and India, with a big manufacturing operation in Singapore. Schering is more focused on China, with a small,...

Posted on March 12, 2009 11:01 AM

Merck probably needs to exit animal health JV (from Corporate Dealmaker)

One of our Monday morning posts on the acquisition of Schering-Plough Corp. (NYSE:SGP) by Merck & Co. (NYSE:MRK) focused on the way the deal will bring Merck into consumer products and boost its presence in animal health, especially the high-growth business of high-tech searches for lost pets.There's since been a...

Posted on March 9, 2009 4:52 PM

Schering deal puts Merck in the lost-pet-finding business (from Corporate Dealmaker)

The press release put out by Merck & Co. (NYSE:MRK) on its $41.1 billion deal to acquire Schering-Plough Corp. (NYSE:SGP) puts heavy emphasis on the pharmaceutical pipeline. There's no mention at all of Schering's substantial consumer products business, which sells such brands as Claritin, Coppertone and Dr. Scholl's.Does Merck, with...

Posted on March 9, 2009 10:19 AM